Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenji Ueshima

Showing results (101-110 of 104) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 104 results.
Hematology (Amsterdam, Netherlands)|February 14, 2022
Bortezomib-cyclophosphamide-dexamethasone induction/consolidation and bortezomib maintenance for transplant-eligible newly diagnosed multiple myeloma: phase 2 multicenter trialHiroyuki Muranushi, Junya Kanda, Masayuki Kobayashi, et al.
Diabetes, Obesity & Metabolism|November 6, 2018
Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy studyHiroshi Itoh, Issei Komuro, Masahiro Takeuchi, et al.
Diabetes Care|April 8, 2018
Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized StudyHiroshi Itoh, Issei Komuro, Masahiro Takeuchi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 18, 2021
JCS 2018 Guideline on Diagnosis of Chronic Coronary Heart DiseasesMasakazu Yamagishi, Nagara Tamaki, Takashi Akasaka, et al.
Pageof 11

Showing results (101-110 of 104) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 104 results.
Hematology (Amsterdam, Netherlands)|February 14, 2022
Bortezomib-cyclophosphamide-dexamethasone induction/consolidation and bortezomib maintenance for transplant-eligible newly diagnosed multiple myeloma: phase 2 multicenter trialHiroyuki Muranushi, Junya Kanda, Masayuki Kobayashi, et al.
Diabetes, Obesity & Metabolism|November 6, 2018
Achieving LDL cholesterol target levels <1.81 mmol/L may provide extra cardiovascular protection in patients at high risk: Exploratory analysis of the Standard Versus Intensive Statin Therapy for Patients with Hypercholesterolaemia and Diabetic Retinopathy studyHiroshi Itoh, Issei Komuro, Masahiro Takeuchi, et al.
Diabetes Care|April 8, 2018
Intensive Treat-to-Target Statin Therapy in High-Risk Japanese Patients With Hypercholesterolemia and Diabetic Retinopathy: Report of a Randomized StudyHiroshi Itoh, Issei Komuro, Masahiro Takeuchi, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|February 18, 2021
JCS 2018 Guideline on Diagnosis of Chronic Coronary Heart DiseasesMasakazu Yamagishi, Nagara Tamaki, Takashi Akasaka, et al.
Pageof 11